Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Recruiting · NCT07776678 · Observational (researchers observe without assigning treatment) · Lead sponsor: Foundation for the National Institutes of Health
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study is to evaluate body composition across a variety of medical, professional, and commercial devices, including: bioelectrical impedance analysis (BIA) devices, 3-dimensional optical imaging (3DO), manual anthropometry measurements, dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and blood tests. The secondary study purpose is to compare body composition measurements from BIA devices, 3DO, and manual anthropometry measurements within a 1-week period for a subset of the study population. The study plans to enroll 300 healthy (having no life-threatening conditions or diseases; male and female) participants, 18 years of age or older.
Who can take part
Inclusion criteria
- Being willing to provide written informed consent prior to participation Being willing to complete the study visits and comply with the study procedures
- Being willing to travel to the various study locations for On-site, DXA, MRI, and Phlebotomy visits
- Being willing to change into appropriate form-fitting clothing for 3DO assessments and/or appropriate gowns for DXA and MRI imaging
- Must have a BMI within the range of 18.5 - 45 kg/m2
- Being willing to refrain from all food, drink, and substances for 8 hours prior to the On-site visit(s) and phlebotomy visit
- Being willing to refrain from all food, drink, and substances for 4 hours prior to the DXA and MRI scan visits
- Being willing to refrain from any exercise or vigorous physical activity for 24 hours prior to all visits
- Stable weight (no more than 5 kg change) for 3 months prior to screening
- If recruited in the Phoenix, AZ area, participants must be willing to drive yourself to the Phoenix Office location for the On-site Visits 1 and 2 (if applicable) located at the Exponent Phoenix Office.
Exclusion criteria
- Being pregnant or attempting to become pregnant
- Having medical implants, such as a pacemaker or metal joint replacements, or other metal implants contraindicated for MRI
- Cosmetic implants, such as breast implants
- Having a height greater than DXA scanning limit (77 inches)
- Having a body weight greater than indicated for the equipment (400 lbs)
- Prior amputation or major body-altering surgery that could invalidate body composition estimates
- Having claustrophobia or a history of claustrophobia
- Known HIV infection
- Known Lipodystrophy
- Known hydration abnormality (e.g., significant edema, end-stage renal disease, end-stage liver disease)
- Severe illness or life-threatening conditions such as end-stage kidney, liver, lung disease, NYHA III-IV heart failure, or active malignancy
Where it is running
3 locations listed across 3 US states.
- Exponent Phoenix - Phoenix, Arizona, United States
- Exponent Menlo Park - Menlo Park, California, United States
- Exponent Boston - Boston, Massachusetts, United States